Literature DB >> 29785842

Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.

Ting Yao1, Qingqing Chen1, Zhouwei Shao1, Zhihua Song1, Liyun Fu2, Bingxiu Xiao1.   

Abstract

BACKGROUND: Circular RNAs (circRNAs) play important roles in disease occurrence. However, the roles of circRNAs in the diagnosis of hepatocellular carcinoma (HCC) are largely unknown. The aim of this study is to investigate the clinical diagnostic values of hsa_circ_0068669 (Alias: hsa_circ_103561), one of the representative HCC-associated circRNAs.
METHODS: Hsa_circ_0068669 expression levels in HCC tissues, HCC cell lines, and chronic hepatitis tissues were detected by real-time quantitative reverse transcription-polymerase chain reaction. Its expression levels between HCC tissues and adjacent non-tumorous tissues were analyzed using paired t test. Independent t test and one-way analysis of variance (ANOVA) were performed to analyze the relationships between hsa_circ_0068669 expression levels and clinicopathological factors of patients with HCC. A receiver operating characteristic (ROC) curve was established to estimate the value of hsa_circ_0068669 as a biomarker in HCC.
RESULTS: Hsa_circ_0068669 expression was significantly downregulated in HCC tissues and HCC cell lines compared with paired non-tumorous tissues and normal hepatic cell line, respectively. Moreover, hsa_circ_0068669 expression in HCC tissues was decreased comparing with chronic hepatitis tissues. Furthermore, hsa_circ_0068669 expression was correlated with microvascular invasion and TNM stages.
CONCLUSIONS: Our findings indicate that hsa_circ_0068669 might be served as a novel potential biomarker for HCC metastasis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; circular RNA; gene expression; hepatocellular carcinoma; metastasis

Mesh:

Substances:

Year:  2018        PMID: 29785842      PMCID: PMC6816935          DOI: 10.1002/jcla.22572

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  33 in total

1.  miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.

Authors:  X Zhou; C Z Zhang; S-X Lu; G G Chen; L-Z Li; L-L Liu; C Yi; J Fu; W Hu; J-M Wen; J-P Yun
Journal:  Oncogene       Date:  2014-03-17       Impact factor: 9.867

Review 2.  The changing pattern of epidemiology in hepatocellular carcinoma.

Authors:  Helena Nordenstedt; Donna L White; Hashem B El-Serag
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

3.  Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.

Authors:  Liyun Fu; Shengdong Wu; Ting Yao; Qingqing Chen; Yi Xie; Sheng Ying; Zhigang Chen; Bingxiu Xiao; Yaoren Hu
Journal:  J Clin Lab Anal       Date:  2017-05-11       Impact factor: 2.352

4.  Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection.

Authors:  Tianwen Li; Yongfu Shao; Liyun Fu; Yi Xie; Linwen Zhu; Weiliang Sun; Rui Yu; Bingxiu Xiao; Junming Guo
Journal:  J Mol Med (Berl)       Date:  2017-11-02       Impact factor: 4.599

5.  Effects of Different Anesthetic Methods on Cellular Immune and Neuroendocrine Functions in Patients With Hepatocellular Carcinoma Before and After Surgery.

Authors:  Hui-Zhen Sun; Yan-Ling Song; Xiang-Yun Wang
Journal:  J Clin Lab Anal       Date:  2016-06-13       Impact factor: 2.352

6.  GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo.

Authors:  Chang Ying; Bo-Duan Xiao; Yun Qin; Bin-Rong Wang; Xin-Yuan Liu; Ru-Wei Wang; Ling Fang; Hui Yan; Xiu-Mei Zhou; Yi-Gang Wang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150

7.  Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.

Authors:  Meilin Qin; Gang Liu; Xisong Huo; Xuemei Tao; Xiaomeng Sun; Zhouhong Ge; Juan Yang; Jia Fan; Lei Liu; Wenxin Qin
Journal:  Cancer Biomark       Date:  2016       Impact factor: 4.388

Review 8.  Circular RNAs: diversity of form and function.

Authors:  Erika Lasda; Roy Parker
Journal:  RNA       Date:  2014-12       Impact factor: 4.942

9.  The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.

Authors:  Lei Yu; Xuejun Gong; Lei Sun; Qiying Zhou; Baoling Lu; Liying Zhu
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

10.  Comprehensive circular RNA profiling reveals that circular RNA100783 is involved in chronic CD28-associated CD8(+)T cell ageing.

Authors:  Yu-Hong Wang; Xu-Hui Yu; Shan-Shun Luo; Hui Han
Journal:  Immun Ageing       Date:  2015-10-08       Impact factor: 6.400

View more
  19 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

Review 2.  Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.

Authors:  Juan Wang; Xiaoya Wang; Xintong Zhang; Tingting Shao; Yanmei Luo; Wei Wang; Yunwei Han
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.

Authors:  Fantian Cheng; Lili Wang; Jun Zhang
Journal:  J Clin Lab Anal       Date:  2020-04-22       Impact factor: 2.352

4.  The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma.

Authors:  Brynjar Mauseth; Ketil André Camilio; Jihua Shi; Clara Louise Hammarström; Øystein Rekdal; Baldur Sveinbjørnsson; Pål-Dag Line
Journal:  Mol Ther Oncolytics       Date:  2019-05-21       Impact factor: 7.200

5.  Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.

Authors:  Qingqin Hao; Yadi Han; Wei Xia; Qinghui Wang; Huizhong Qian
Journal:  Can J Gastroenterol Hepatol       Date:  2019-05-02

6.  Diagnostic performance of circular RNAs in human cancers: A systematic review and meta-analysis.

Authors:  Juan Li; Hang Li; Xiaoting Lv; Zitai Yang; Min Gao; Yanhong Bi; Ziwei Zhang; Shengli Wang; Zhigang Cui; Baosen Zhou; Zhihua Yin
Journal:  Mol Genet Genomic Med       Date:  2019-05-20       Impact factor: 2.183

7.  Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Guang-Lei Qiao; Li Chen; Wei-Hua Jiang; Cheng Yang; Chun-Mei Yang; Li-Na Song; Ying Chen; Hong-Li Yan; Li-Jun Ma
Journal:  Onco Targets Ther       Date:  2019-07-19       Impact factor: 4.147

Review 8.  Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.

Authors:  Jin-Yu Sun; Xiao-Yu Zhang; Yi-Zhi Cao; Xiao Zhou; Jian Gu; Xiao-Xin Mu
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

Review 9.  Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma.

Authors:  Man Wang; Fei Yu; Peifeng Li
Journal:  Cancers (Basel)       Date:  2018-08-02       Impact factor: 6.639

10.  Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma.

Authors:  Qi Lu; Tao Fang
Journal:  J Clin Lab Anal       Date:  2019-12-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.